Abstract
Microscale 3D printing is rapidly transforming the pharmaceutical landscape, offering unprecedented precision and customization in drug formulation and drug delivery systems. This paper explores the current state of the field, highlighting key findings and emerging trends. Microscale 3D printing enables the creation of patient-specific dosages and personalized dosage forms, ushering in an era of precision medicine. Integration with biopharmaceuticals presents novel opportunities in regenerative medicine, with the potential for organ and tissue production. Moreover, the technology holds promise for cost savings and ethical considerations, though challenges in regulation and data protection loom. The future of microscale 3D printing in pharmaceuticals is one of precision, customization and promise, where healthcare is patient-centric and costeffective. This paper provides a comprehensive overview of the subject and underscores the transformative power of this technology.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
